Expression of human IAP-like protein in skeletal muscle: a possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathies

被引:39
作者
Li, M [1 ]
Dalakas, MC [1 ]
机构
[1] NINDS, Neuromuscular Dis Sect, NIH, Bethesda, MD 20892 USA
关键词
hILP; apoptosis; myopathies;
D O I
10.1016/S0165-5728(99)00162-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In Polymyositis (PM) and sporadic Inclusion Body Myositis (s-IBM), the CD8(+) cytotoxic T cells invade the muscle membrane and release perforin and granzyme B to induce cell death. Although granzyme B is a direct activator of executioner caspases, there is no convincing evidence of apoptosis in the muscle fibers of these patients. To search for an explanation, we examined the muscle expression of the human IAP-Like Protein (hILP), an evolutionarily conserved cell death suppressor, that exerts major anti-apoptotic effects by inhibiting the executioner caspases. Muscle biopsy specimens from patients with inflammatory myopathies and controls were studied with: (a) immunocytochemistry using antibodies against hILP and caspase-3 in single and double-labeled confocal laser microscopy; (b) immunoblotting of muscle extracts immunoreacted with anti-hILP antibodies; and (c) subcellular fractionation of muscle lysates immunoreacted with antibodies against hILP. We found that hILP is expressed on the sarcolemmal region and co-localizes with dystrophin. Caspase-3 is undetectable. Subcellular fractionation of the muscle specimens confirmed that hILP is a membrane-associated protein. By immunoblotting, the 57 kD hILP was abundantly expressed in the normal as well as the diseased muscles. We conclude that in s-IBM and PM the expression of hILP, a major cell death suppressor, on the muscle membrane may prevent the induction of apoptosis by the autoinvasive cytotoxic T cells on the cell surface, by inhibiting the caspase activation. (C) 2000 Published by Elsevier Science BN. All rights reserved.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 23 条
[1]   Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IκBα/NF-κB pathway in limb-girdle muscular dystrophy type 2A [J].
Baghdiguian, S ;
Martin, M ;
Richard, I ;
Pons, F ;
Astier, C ;
Bourg, N ;
Hay, RT ;
Chemaly, R ;
Halaby, G ;
Loiselet, J ;
Anderson, LVB ;
de Munain, AL ;
Fardeau, M ;
Mangeat, P ;
Beckmann, JS ;
Lefranc, G .
NATURE MEDICINE, 1999, 5 (05) :503-511
[2]   Cytotoxic mechanisms in inflammatory myopathies - Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells [J].
Behrens, L ;
Bender, A ;
Johnson, MA ;
Hohlfeld, R .
BRAIN, 1997, 120 :929-938
[3]   Molecular immunology and genetics of inflammatory muscle diseases [J].
Dalakas, MC .
ARCHIVES OF NEUROLOGY, 1998, 55 (12) :1509-1512
[4]   POLYMYOSITIS, DERMATOMYOSITIS, AND INCLUSION-BODY MYOSITIS [J].
DALAKAS, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) :1487-1498
[5]   X-linked IAP is a direct inhibitor of cell-death proteases [J].
Deveraux, QL ;
Takahashi, R ;
Salvesen, GS ;
Reed, JC .
NATURE, 1997, 388 (6639) :300-304
[6]   IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases [J].
Deveraux, QL ;
Roy, N ;
Stennicke, HR ;
Van Arsdale, T ;
Zhou, Q ;
Srinivasula, SM ;
Alnemri, ES ;
Salvesen, GS ;
Reed, JC .
EMBO JOURNAL, 1998, 17 (08) :2215-2223
[7]   Human IAP-like protein regulates programmed cell death downstream of Bcl-xL and cytochrome c [J].
Duckett, CS ;
Li, F ;
Wang, Y ;
Tomaselli, KJ ;
Thompson, CB ;
Armstrong, RC .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (01) :608-615
[8]   A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors [J].
Duckett, CS ;
Nava, VE ;
Gedrich, RW ;
Clem, RJ ;
VanDongen, JL ;
Gilfillan, MC ;
Shiels, H ;
Hardwick, JM ;
Thompson, CB .
EMBO JOURNAL, 1996, 15 (11) :2685-2694
[9]   Upregulation of Fas/Fas ligand in inclusion body myositis [J].
Fyhr, IM ;
Oldfors, A .
ANNALS OF NEUROLOGY, 1998, 43 (01) :127-130
[10]   Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis [J].
Goebels, N ;
Michaelis, D ;
Engelhardt, M ;
Huber, S ;
Bender, A ;
Pongratz, D ;
Johnson, MA ;
Wekerle, H ;
Tschopp, J ;
Jenne, D ;
Hohlfeld, R .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2905-2910